Semper Paratus Acquisition C
13F holders, Q4 2025 (December 31)1holders −2
0new positions
2sold out
$0.33avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Semper Paratus Acquisition C in their 13F filings, down 2 from Q3 2025. 0 opened new positions and 2 sold out. The largest holder was Parallel Advisors, LLC ($13).
- Company
- Semper Paratus Acquisition C
- Filed as
- TEVOGEN BIO HLDGS INC COM (Q4 2025)
- CUSIP
- G8028L107
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $574 |
All 13F filers, Q3 2025 → Q4 2025: 731 shares sold, net −731 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Parallel Advisors, LLC | 0.00% | No change | 40 | $13 |
"% of holder's portfolio" is SEMPER PARATUS ACQUISITION C's weight in each manager's 13F, not the share of Semper Paratus Acquisition C the manager owns.